ArticleResearch square2023

Onabotulinum toxin A vs. incobotulinum toxin A for the treatment of chronic migraine: a retrospective review.

Scott Lucchese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.